Alzheimer’s Screening Takes a Leap with Japan’s Machine Learning Model

In a groundbreaking development, Japan-based Oita University and pharmaceutical company Eisai Co. have unveiled the world’s inaugural machine learning model designed to predict the accumulation of amyloid beta (Aβ) in the brain, a pivotal pathological factor in Alzheimer’s disease (AD). This revolutionary model leverages data collected from wristband sensors to easily screen brain Aβ accumulation…